Physician profile
Barry D Winston
NPI 1063478725
$2,226.24
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $792 · 2020: $533 · 2021: $858 · 2022: $15.40 · 2024: $28.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $28.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $28.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $580.50 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $394.13 | 2019-2021 | |
| Janssen Biotech, INC. | $323.70 | 2019-2021 | |
| Amgen INC. | $210.67 | 2021 | |
| Redhill Biopharma INC. | $150.37 | 2020-2021 | |
| Janssen Scientific Affairs, LLC | $123.65 | 2020 | |
| Romark Laboratories, Lc | $82.15 | 2019 | |
| Celgene Corporation | $57.41 | 2021 | |
| Ironwood Pharmaceuticals, INC | $54.92 | 2019-2020 | |
| Ferring Pharmaceuticals INC. | $49.64 | 2020 | |
| Pfizer INC. | $36.37 | 2021 | |
| Ucb, INC. | $33.15 | 2020 | |
| Mallinckrodt Hospital Products INC. | $28.00 | 2024 | Acthar |
| Intercept Pharmaceuticals, INC. | $22.96 | 2021 | |
| Abbvie INC. | $19.88 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alfasigma USA, INC. | $16.29 | 2020 | |
| Braintree Laboratories, INC. | $16.03 | 2019 | |
| Conmed Corporation | $15.00 | 2019 | |
| Allergan, INC. | $11.42 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Barry Winston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.